Meiziya Kang CQ20 Capsules
Meiziya Kang CQ20 Capsules : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Contains red yeast rice. Monacolins must remain below 3 mg per daily portion, with mandatory warnings on the label. The monacolin content is not declared in Compl'Alim.
annexe III, partie B (règlement (UE) 2022/860). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026, source updated 26 November 2025.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Monascus purpureus | Monascus purpureus[333 mg,450 mg] | Not identified |
| Glycine max | Glycine max[50 mg,450 mg] | Not identified |
| Salvia miltiorrhiza | Salvia miltiorrhiza[67 mg,450 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL20086102T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- MEIZIYA INTERNATIONAL SDN. BHD.
- Manufacturer
- WAN YEEN TRADING SDN. BHD.
- Registration period starting
- 2025-08-22
- Published validity end
- 2030-08-22
Original register data
View published fields and their variants
- Active ingredients
- Monascus purpureus[333 mg,450 mg],Glycine max[50 mg,450 mg],Salvia miltiorrhiza[67 mg,450 mg]
- Valid until
- 2030-08-22
- Registration date
- 2025-08-22
- Published description
- NATURAL PRODUCT
- Licence holder
- MEIZIYA INTERNATIONAL SDN. BHD.
- Producer
- WAN YEEN TRADING SDN. BHD.
- Published name
- Meiziya Kang CQ20 Capsules
- Published reference
- 202002203461T
- Registration number
- MAL20086102T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20086102T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Glycine max
Read the warning, when it applies and the studies cited
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Meiziya Kang CQ20 Capsules”, https://compoatlas.com/en/supplements/malaysia/MAL20086102T-meiziya-kang-cq20-capsules, updated 27 October 2026.